116 related articles for article (PubMed ID: 27914769)
1. Clinicopathological and molecular characteristics of Ku 70/80 expression in Nigerian breast cancer and its potential therapeutic implications.
Agboola AO; Ebili HO; Iyawe VO; Banjo AA; Salami BA; Rakha EA; Nolan CC; Ellis IO; Green AR
Pathol Res Pract; 2017 Jan; 213(1):27-33. PubMed ID: 27914769
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological significance of KU70/KU80, a key DNA damage repair protein in breast cancer.
Alshareeda AT; Negm OH; Albarakati N; Green AR; Nolan C; Sultana R; Madhusudan S; Benhasouna A; Tighe P; Ellis IO; Rakha EA
Breast Cancer Res Treat; 2013 Jun; 139(2):301-10. PubMed ID: 23624778
[TBL] [Abstract][Full Text] [Related]
3. Molecular characteristics and prognostic features of breast cancer in Nigerian compared with UK women.
Agboola AJ; Musa AA; Wanangwa N; Abdel-Fatah T; Nolan CC; Ayoade BA; Oyebadejo TY; Banjo AA; Deji-Agboola AM; Rakha EA; Green AR; Ellis IO
Breast Cancer Res Treat; 2012 Sep; 135(2):555-69. PubMed ID: 22842985
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and molecular significance of Sumolyation marker (ubiquitin conjugating enzyme 9 (UBC9)) expression in breast cancer of black women.
Agboola AO; Musa AA; Ayoade BA; Banjo AA; Anunobi CC; Deji-Agboola AM; Rakha EA; Nolan C; Ellis IO; Green AR
Pathol Res Pract; 2014 Jan; 210(1):10-7. PubMed ID: 24176171
[TBL] [Abstract][Full Text] [Related]
5. Molecular profiling of breast cancer in Nigerian women identifies an altered p53 pathway as a major mechanism underlying its poor prognosis compared with British counterpart.
Agboola AO; Banjo AA; Anunobi CC; Ayoade BA; Deji-Agboola AM; Musa AA; Abdel-Fatah T; Nolan CC; Rakha EA; Ellis IO; Green AR
Malays J Pathol; 2014 Apr; 36(1):3-17. PubMed ID: 24763230
[TBL] [Abstract][Full Text] [Related]
6. PIASγ expression in relation to clinicopathological, tumour factors and survival in indigenous black breast cancer women.
Agboola A; Musa A; Banjo A; Ayoade B; Deji-Agboola M; Nolan C; Rakha E; Ellis I; Green A
J Clin Pathol; 2014 Apr; 67(4):301-6. PubMed ID: 24170211
[TBL] [Abstract][Full Text] [Related]
7. Tumour cell membrane laminin expression is associated with basal-like phenotype and poor survival in Nigerian breast cancer.
Agboola AO; Ebili HO; Iyawe VO; Banjo AA; Salami BS; Rakha EA; Nolan C; Ellis IO; Green AR
Malays J Pathol; 2016 Aug; 38(2):83-92. PubMed ID: 27568664
[TBL] [Abstract][Full Text] [Related]
8. Increased ID4 expression, accompanied by mutant p53 accumulation and loss of BRCA1/2 proteins in triple-negative breast cancer, adversely affects survival.
Thike AA; Tan PH; Ikeda M; Iqbal J
Histopathology; 2016 Apr; 68(5):702-12. PubMed ID: 26259780
[TBL] [Abstract][Full Text] [Related]
9. Checkpoint Kinase 1 Expression Predicts Poor Prognosis in Nigerian Breast Cancer Patients.
Ebili HO; Iyawe VO; Adeleke KR; Salami BA; Banjo AA; Nolan C; Rakha E; Ellis I; Green A; Agboola AOJ
Mol Diagn Ther; 2018 Feb; 22(1):79-90. PubMed ID: 29075961
[TBL] [Abstract][Full Text] [Related]
10. The microRNA maturation regulator Drosha is an independent predictor of outcome in breast cancer patients.
Khoshnaw SM; Rakha EA; Abdel-Fatah T; Nolan CC; Hodi Z; Macmillan RD; Ellis IO; Green AR
Breast Cancer Res Treat; 2013 Jan; 137(1):139-53. PubMed ID: 23225145
[TBL] [Abstract][Full Text] [Related]
11. Expression of BRCA1 protein in breast cancer and its prognostic significance.
Rakha EA; El-Sheikh SE; Kandil MA; El-Sayed ME; Green AR; Ellis IO
Hum Pathol; 2008 Jun; 39(6):857-65. PubMed ID: 18400253
[TBL] [Abstract][Full Text] [Related]
12. DNA damage response markers are differentially expressed in BRCA-mutated breast cancers.
Aleskandarany M; Caracappa D; Nolan CC; Macmillan RD; Ellis IO; Rakha EA; Green AR
Breast Cancer Res Treat; 2015 Feb; 150(1):81-90. PubMed ID: 25690937
[TBL] [Abstract][Full Text] [Related]
13. Biological and clinical significance of PARP1 protein expression in breast cancer.
Green AR; Caracappa D; Benhasouna AA; Alshareeda A; Nolan CC; Macmillan RD; Madhusudan S; Ellis IO; Rakha EA
Breast Cancer Res Treat; 2015 Jan; 149(2):353-62. PubMed ID: 25528020
[TBL] [Abstract][Full Text] [Related]
14. Association of Cytokeratin 5 and Claudin 3 expression with BRCA1 and BRCA2 germline mutations in women with early breast cancer.
Danzinger S; Tan YY; Rudas M; Kastner MT; Weingartshofer S; Muhr D; Singer CF
BMC Cancer; 2019 Jul; 19(1):695. PubMed ID: 31307407
[TBL] [Abstract][Full Text] [Related]
15. Low expression of Ku70/80, but high expression of DNA-PKcs, predict good response to radiotherapy in early breast cancer.
Söderlund Leifler K; Queseth S; Fornander T; Askmalm MS
Int J Oncol; 2010 Dec; 37(6):1547-54. PubMed ID: 21042724
[TBL] [Abstract][Full Text] [Related]
16. Comparisons of p53, KI67 and BRCA1 expressions in patients with different molecular subtypes of breast cancer and their relationships with pathology and prognosis.
Li Y; Zhang X; Qiu J; Pang T; Huang L; Zeng Q
J BUON; 2019; 24(6):2361-2368. PubMed ID: 31983107
[TBL] [Abstract][Full Text] [Related]
17. Strong association of fascin expression with triple negative breast cancer and basal-like phenotype in African-American women.
Esnakula AK; Ricks-Santi L; Kwagyan J; Kanaan YM; DeWitty RL; Wilson LL; Gold B; Frederick WA; Naab TJ
J Clin Pathol; 2014 Feb; 67(2):153-60. PubMed ID: 23986556
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological significance of ARID1B in breast invasive ductal carcinoma.
Shao F; Guo T; Chua PJ; Tang L; Thike AA; Tan PH; Bay BH; Baeg GH
Histopathology; 2015 Nov; 67(5):709-18. PubMed ID: 25817822
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological significance and potential drug target of CDH1 in breast cancer: a meta-analysis and literature review.
Huang R; Ding P; Yang F
Drug Des Devel Ther; 2015; 9():5277-85. PubMed ID: 26425077
[TBL] [Abstract][Full Text] [Related]
20. IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype.
Walter O; Prasad M; Lu S; Quinlan RM; Edmiston KL; Khan A
Hum Pathol; 2009 Nov; 40(11):1528-33. PubMed ID: 19695680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
